Literature DB >> 19415660

Novel 3,6-disubstituted 7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines: synthesis, characterization, and evaluation of analgesic/anti-inflammatory, antioxidant activities.

Birsen Tozkoparan1, Sevim Peri Aytaç, Göknur Aktay.   

Abstract

In this study, the synthesis of a new series of 3,6-disubstituted-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazine 1a-4c compounds derived from 4-amino-3-substituted-1,2,4-triazole-5-thiones 1-4 is described. All of the synthesized compounds were screened for their possible analgesic / anti-inflammatory, antioxidant activities and gastric toxicity. The compound 2c was found to have both significant analgesic and consistent anti-inflammatory activity without inducing any gastric lesions along with minimal lipid peroxidation. A deep insight into the structures of the active compounds revealed that the compounds carrying an electron withdrawing group (a chloride or fluoride) on the phenyl ring at 6-position of the condensed heterocyclic derivatives exhibited noticeable higher activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415660     DOI: 10.1002/ardp.200800188

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

1.  Chemical genetic screening for compounds that preferentially inhibit growth of methylthioadenosine phosphorylase (MTAP)-deficient Saccharomyces cerevisiae.

Authors:  Yuwaraj Kadariya; Baiqing Tang; Cynthia B Myers; Jami Fukui; Jeffrey R Peterson; Warren D Kruger
Journal:  J Biomol Screen       Date:  2010-12-03

2.  Synthesis and pharmacological activities of some new 3-substituted-4-amino-5-mercapto-1,2,4-triazoles.

Authors:  Shobha R Desai; U Laddi; Rajani S Bennur; P A Patil; S Bennur
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

3.  A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation.

Authors:  Deniz Cansen Kahraman; Ebru Bilget Guven; Peri S Aytac; Gamze Aykut; Birsen Tozkoparan; Rengul Cetin Atalay
Journal:  Sci Rep       Date:  2022-09-07       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.